JPRN-UMIN000000754已完成未知
Study on the efficacy of alternate day mizoribine pulse therapy for lupus nephrits - Study on the efficacy of alternate day mizoribine pulse therapy for lupus nephrits
Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences,University of Tsukuba0 个研究点目标入组 10 人开始时间: 2007年6月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pregnant women or lactating mothers 2)Patients having complications such as marrow suppression, infectious diseases, ulcer disease 3)GFR < 30 ml/min 4)Patients with allergy with Mizoribin
研究者
相似试验
已完成
2 期
Phase II study of alternate-day administrations of S-1 as 2nd-line treatment in patients with metastatic and locally advanced pancreatic cancerMetastatic or locally advanced pancreatic cancerJPRN-UMIN000003454Pancreatic Cancer Treatment Research Group45
已完成
2 期
Phase II Study of Alternate-day Administration of S-1 plus Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Canceron-small Cell Lung CancerJPRN-UMIN000012098Tokushukai Group Oncology Project45
已完成
2 期
Phase II Study of Alternate-day Administration of S-1 plus Carboplatin in Elderly Patients with Previously Treated Non-small Cell Lung CancerJPRN-UMIN000010989Tokushukai Group Oncology Project32
已完成
2 期
Efficacy and safety of mizoribine for patients with Sjogren's syndrome in pediatric ageSjogren's syndrome in pediatric ageJPRN-UMIN000004237Graduate School of Medicine, Chiba University5
已完成
1 期
A phase I study of alternate-day administration of S-1 plus leucovorin with bevacizumab in patients with refractory metastatic colorectal cancer.colorectal cancerJPRN-UMIN000016094Aichi Cancer Center Hospital16